We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
The epidemiology, symptoms, diagnosis and management of severe fever with thrombocytopaenia syndrome (SFTS).
Clarification for the interpretation of the new elements within the Veterinary Medicines Regulations (VMRs), as amended, relating to combating antimicrobial resistance (AMR).
Information on the clinical management of acute flaccid paralysis (AFP) and acute flaccid myelitis (AFM), for use by healthcare professionals.
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
How to reduce the risk of Lyme disease, its clinical management and other useful resources.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Examples of viral haemorrhagic fevers (VHFs) include Lassa fever, Crimean-Congo haemorrhagic fever, Marburg and Ebola virus diseases.
We want to remind healthcare professionals that use of systemic (oral and injectable) NSAIDs such as ibuprofen, naproxen, and diclofenac is contraindicated in the last trimester of pregnancy (after 28 weeks of pregnancy).
Information on acetone (also known as propanone) for use in responding to chemical incidents.
Guidance primarily aimed at local responders covering some common issues that may arise during the Recovery Phase of an emergency in the UK.
A list of all documents relating to JSP 375: Management of health and safety in defence.
Information on bromine, for responding to chemical incidents.
Resources to support the commissioning and delivery of tier 2 behavioural weight management services for children, families and adults.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).